Crossmark

Alpha-1 antitrypsin augmentation therapy decreases miR-199a-5p, miR-598 and miR-320a expression in monocytes via inhibition of NFκB

Published Online: 2017-10-23

Authors

Hassan, Tidi

de Santi, Chiara

Mooney, Catherine

McElvaney, Noel G.

Greene, Catherine M.
License Information

Text and Data Mining valid from 2017-10-23

Version of Record valid from 2017-10-23
More Information

Article History

Received: 18 May 2017

Accepted: 9 October 2017

First Online: 23 October 2017

Competing Interests

: The authors declare that they have no competing interests.

Document is current